Product Name: 2-(tert-Butylamino)acetic acid hydrochloride CAS NO:6939-23-7
Glycine, N-(1,1-dimethylethyl)-, hydrochloride;
Chemical & Physical Properties:
Appearance :white solid
Boiling Point:247.1℃ at 760 mmHg
N-(2-Methyl-2-propanyl)glycine hydrochloride is used to Tigecycline intermediate.
Tigecycline, also known as 9-tert-butylglycylaminominocycline or bumminocycline, is a new type of broad-spectrum active intravenous antibiotics, which belongs to 9-tert-butylglycinamide The minocycline derivative, the first glycylcycline antibiotic, was developed to solve the early resistance of tetracycline, and was approved by the US FDA in June 1995.
Tigecycline can be used as a choice after the first-line treatment of multi-drug resistant bacteria, and it is still a new treatment option for patients who are allergic to penicillin or cannot tolerate other drugs. It is used in the treatment of 18-year-old and patients with complicated skin and skin structure infections or complicated intra-abdominal infections over the age of 18, including complex appendicitis, burn infection, intra-abdominal abscess, deep soft tissue infection and ulcer infection.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.